Human erythrocyte pyruvate kinase: characterization of the recombinant enzyme and a mutant form (R510Q) causing nonspherocytic hemolytic anemia
Open Access
- 15 November 2001
- journal article
- Published by American Society of Hematology in Blood
- Vol. 98 (10) , 3113-3120
- https://doi.org/10.1182/blood.v98.10.3113
Abstract
Human erythrocyte pyruvate kinase plays an important role in erythrocyte metabolism. Mutation on the gene results in pyruvate kinase deficiency and is an important cause of hereditary nonspherocytic hemolytic anemia. Because of difficulties in isolating the mutant enzymes from patients, these mutations have not been fully studied. In this study, a complementary DNA (cDNA) encoding the human erythrocyte pyruvate kinase was generated. The cDNA was cloned into several expression vectors, and the protein was expressed and purified. The tetrameric protein exhibited properties characteristic of authentic human erythrocyte pyruvate kinase, including response to substrate, phosphoenolpyruvate, activation by fructose 1,6-bisphosphate, and inhibition by adenosine triphosphate (ATP). The N-terminal segment of the protein was highly susceptible to proteolysis, but only 2 of the 4 subunits were cleaved and lacked 47 N-terminal amino acid residues. A mutant protein, R510Q, which is the most frequently occurring mutation among Northern European population, was also generated and purified. The mutant protein retained its binding capacity to and could be activated by fructose 1,6-bisphosphate and showed similar kinetics toward phosphoenolpyruvate and adenosine diphosphate as for the wild-type enzyme. Conversely, the mutant protein has a dramatically decreased stability toward heat and is more susceptible to ATP inhibition. The enzyme instability decreases the enzyme level in the cell, accounting for the clinically observed “pyruvate kinase deficiency” of patients who are homozygous for this mutation. This study provides the first detailed functional characterization of human erythrocyte pyruvate kinase. These findings will allow the establishment of a fine correlation between molecular abnormalities and the clinical expression of the disease.Keywords
This publication has 40 references indexed in Scilit:
- The structure of pyruvate kinase from Leishmania mexicana reveals details of the allosteric transition and unusual effector specificity 1 1Edited by I. A. WilsonJournal of Molecular Biology, 1999
- Structure of Rabbit Muscle Pyruvate Kinase Complexed with Mn2+, K+, and PyruvateBiochemistry, 1994
- A kinetic study of the pH effect on the allosteric properties of pyruvate kinase from Phycomyces blakesleeanusBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1989
- Phosphorylation of Human Erythrocyte Pyruvate Kinase by Soluble Cyclic‐AMP‐Dependend Protein KinasesEuropean Journal of Biochemistry, 1980
- Proteolytic processing of human erythrocyte pyruvate kinase: Study of normal and deficient enzymesBiochemical and Biophysical Research Communications, 1979
- Recommended Methods for the Characterization of Red Cell Pyruvate Kinase Variants.British Journal of Haematology, 1979
- Endogenous, cyclic 3′-2-5′ AMP-dependent phosphorylation of human red cell pyruvate kinaseBiochemical and Biophysical Research Communications, 1979
- Three-dimensional structure of cat muscle pyruvate kinase at 6 Å resolutionJournal of Molecular Biology, 1975
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Thermodynamic considerations on erythrocyte glycolysisBiochemical and Biophysical Research Communications, 1965